0001209191-19-037147.txt : 20190614
0001209191-19-037147.hdr.sgml : 20190614
20190614163343
ACCESSION NUMBER: 0001209191-19-037147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190612
FILED AS OF DATE: 20190614
DATE AS OF CHANGE: 20190614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nicholson Garry A
CENTRAL INDEX KEY: 0001640861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 19899349
MAIL ADDRESS:
STREET 1: C/O TESARO, INC.
STREET 2: 1000 WINTER STREET, SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-12
0
0001560241
G1 Therapeutics, Inc.
GTHX
0001640861
Nicholson Garry A
C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR.
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK
NC
27709
1
0
0
0
Stock Option (right to buy)
18.47
2019-06-12
4
A
0
20000
0.00
A
2029-06-12
Common Stock
20000
20000
D
Stock Option (right to buy)
18.47
2019-06-12
4
A
0
100000
0.00
A
2029-06-12
Common Stock
100000
100000
D
The shares underlying this option will vest in their entirety twelve months after June 12, 2019, subject to the Reporting Person's continued service as a director.
The shares underlying this option will vest in equal monthly installments over a period of three years, subject to the Reporting Person's continuing service as a Chairman of the board of directors.
James Stillman Hanson, attorney-in-fact
2019-06-14